Breathomics to monitor interstitial lung disease associated with systemic sclerosis

Thibault Massenet; Judith Potjewijd; Rachid Tobal; Fanny Gester; Delphine Zanella; Monique Henket; Makon-Sébastien Njock; Thibaut Dejong; Gregory Gridelet; Laurie Giltay; Françoise Guissard; Béatrice André; Clio Ribbens; Renaud Louis; Pieter Van Paassen; Julien Guiot; Pierre-Hugues Stefanuto

doi:10.1183/23120541.00175-2024

Breathomics to monitor interstitial lung disease associated with systemic sclerosis

ERJ Open Res. 2024 Sep 16;10(4):00175-2024. doi: 10.1183/23120541.00175-2024. eCollection 2024 Jul.

Authors

Thibault Massenet¹, Judith Potjewijd², Rachid Tobal², Fanny Gester³, Delphine Zanella¹, Monique Henket³, Makon-Sébastien Njock³, Thibaut Dejong¹, Gregory Gridelet¹, Laurie Giltay³, Françoise Guissard³, Béatrice André⁴, Clio Ribbens⁴, Renaud Louis³, Pieter Van Paassen², Julien Guiot^{3

5}, Pierre-Hugues Stefanuto^{1

5}

Affiliations

¹ Molecular System, Organic & Biological Analytical Chemistry Group, University of Liège, Liege, Belgium.
² Department of Internal Medicine, Division of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
³ Respiratory Medicine, CHU Liège, Liege, Belgium.
⁴ Rheumatology Department, CHU Liège, Liege, Belgium.
⁵ J. Guiot and P-H. Stefanuto contributed equally as senior authors.

Abstract

Exhaled breath analysis, utilising VOCs, offers promise in identifying SSc-ILD patients, aiding targeted treatment. Further multicentric studies are crucial for validation and exploring longitudinal VOC changes for comprehensive disease management. https://bit.ly/4aKMYif.